Company Description
111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China.
It operates through two segments, B2C and B2B. The company offers supply chain integration services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education, and brand awareness services; and marketing and channel data services.
It also provides 1 Pharmacy online wholesale pharmacy that offers pharmaceutical and other health and wellness products; and 1 Medicine Marketplace online retail pharmacy that provides pharmaceutical products and other merchandise.
In addition, the company offers online loan application services; cloud-based inventory management services; smart procurement services, which collect pharmacies’ historical purchase orders and inventory data; and Hawkeye automated salesforce tool, as well as online consultation, e-prescription, and data services.
Further, its pharmacies provide drugs, including prescription and over-the-counter drugs comprising Western and Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices that consists of bandages and thermometers; and personal care products that include skin care, birth control, sexual wellness, and baby products.
Additionally, the company offers research and development, and consulting services; warehousing, procurement, and logistics services; and software development and information technology support services.
It serves pharmacies, pharmaceutical companies, medical professionals, and marketplace sellers. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018.
111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.
| Country | China |
| Founded | 2010 |
| Industry | Medical Distribution |
| Sector | Healthcare |
| Employees | 1,238 |
| CEO | Junling Liu |
Contact Details
Address: No.295 ZuChongZhi Road, 3-4/F Shanghai, 201203 China | |
| Phone | 86 21 2053 6666 |
| Website | corporate.111.com.cn |
Stock Details
| Ticker Symbol | YI |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| CIK Code | 0001738906 |
| CUSIP Number | 68247Q102 |
| ISIN Number | US68247Q2012 |
| SIC Code | 5912 |
Key Executives
| Name | Position |
|---|---|
| Junling Liu | Co-Founder, Acting Chief Financial Officer, Chairman and Chief Executive Officer |
| Dr. Gang Yu Ph.D. | Co-Founder and Executive Chairman |
| Haihui Wang | Co-Chief Operating Officer |
| Pengcheng Zhu | Co-Chief Operating Officer |
| Monica Mu | IR Director |
| Anfeng Guo | Chief Innovation Officer |
| Alex Liu | Finance Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 20, 2025 | 6-K | Report of foreign issuer |
| Apr 29, 2025 | 20-F | Annual and transition report of foreign private issuers |
| Mar 20, 2025 | 6-K | Report of foreign issuer |
| Feb 11, 2025 | 6-K | Report of foreign issuer |
| Jan 8, 2025 | 6-K | Report of foreign issuer |
| Nov 27, 2024 | 6-K | Report of foreign issuer |
| Nov 4, 2024 | 6-K | Report of foreign issuer |
| Aug 29, 2024 | 6-K | Report of foreign issuer |
| Jul 19, 2024 | 6-K | Report of foreign issuer |
| May 23, 2024 | 6-K | Report of foreign issuer |